Abstract:
PROBLEM TO BE SOLVED: To provide a method for easily manufacturing liquid carotenoid preparation.SOLUTION: The method is a manufacturing method in which hydrophilic protection colloid of carotenoid and starch octenylsuccinate, and the like, is dispersed in water-miscible alcohol of glycerol, and the like, and crashing is continued until average particle size of a carotenoid crystal and hydrophilic protection colloid reaches to less than 5 μm.
Abstract:
The invention relates to the production of solutions of astaxanthin derivatives in edible oils and to solutions of astaxanthin derivatives in an edible oil that can be obtained by said method. The inventive method comprises: i) provision of a suspension of an astaxanthin derivative in an edible oil, the particles of the astaxanthin derivative in the suspension having an average volumetric particle diameter, determined by Fraunhofer diffraction, ranging between 0.5 and 50 µm, and ii) the suspension of the astaxanthin derivative is worked into an edible oil to produce a solution of the astaxanthin derivative of formula (I), at least 70 % by weight of said astaxanthin derivative being composed of a compound of formula (I). In said formula, R represents a group of formula (II), # represents the bond with the carbonyl group, A stands for linear or branched C1-C6alkene or for -CH=CH- and Rx stands for C1-C10 alkyl.
Abstract:
The invention relates to formulations of an astaxanthin derivative, comprising a continuous oil phase with at least one oil that is suitable for foodstuffs and an aqueous phase that is emulsified in the oil phase, the astaxanthin derivative being present in the aqueous phase in the form of dispersed particles that are stabilised by at least one protective colloid. The astaxanthin derivative consists of at least 70 % by weight, preferably at least 80 % by weight, in particular at least 90 % by weight and especially 96 % by weight of a compound of formula (I) below. In formula (I), R represents a group of formula (III), where # is the link to the carbonyl group, A represents -CH2CH2- or -CH=CH- and Rx represents C1-C4 alkyl.
Abstract:
The invention relates to astaxanthin compositions for use in foods, food supplements or animal feed or as a medicament. (Formula (A)) Astaxanthin compositions, which contain at least 50 wt.%, in particular at least 60 wt.%, more particularly at least 70 wt.%, and especially at least 80 wt.% or at least 90 wt.%, relative to the total weight of astaxanthin and astaxanthin derivatives in the composition, a monoester of the astaxanthin having C18-1 - fatty acid, have a particularly high bioavailability. They are therefore particularly suitable for use in foods, food supplements or animal feed and for therapeutic use as a medicament and as an ingredient for medical preparations or pharmaceutical agents.
Abstract:
Uso de composiciones de astaxantina en alimentos, suplementos alimenticios o alimentos para animales, en el que la composición de astaxantina contiene al menos el 90 % en peso, con respecto al peso total de astaxantina y derivados de astaxantina en la composición, de monoésteres de la astaxantina con un ácido graso C18-1.
Abstract:
Formulación sólida de derivados de astaxantina en forma de una solución o suspensión sólida del derivado deastaxantina en un agente diluyente adecuado para alimentos que exhibe un punto de fusión de por lo menos 40 °C yque es elegido de entre ácidos grasos, ésteres de ácidos grasos, alcoholes grasos y ceras adecuados paraalimentos con un punto de fusión de por lo menos 40 °C y sus mezclas, donde el derivado de astaxantina consisteen por lo menos 70 % en peso de por lo menos un compuesto de la fórmula I donde R un representa un radical de la fórmula donde representa la unión a los grupos carbonilo, A representa -CH2CH2- o representa -CH>=CH- y Rx representaalquilo C1-C4.
Abstract:
Composición pulverulentas que contiene al menos un derivado de astaxantina en una cantidad de al menos un50 % en peso, referido al peso total de la composición, donde al menos un 90 % en peso de partículas de polvopresentan un diámetro de partícula por debajo de 100 μm, y las partículas de polvo presentan un tamaño departícula medio (media volumétrica) en el intervalo de 0,5 a 50 μm, y estando constituido el derivado de astaxantinaen al menos un 70 % en peso por al menos un compuesto de la fórmula I donde R representa un resto de la fórmula donde significa el enlace al grupo carbonilo, A representa -CH2CH2- o -CH>=CH-, y Rx representa alquilo con 1 a 4átomos de carbono.
Abstract:
The invention relates to astaxanthin compositions for use in foods, food supplements or animal feed or as a medicament. Astaxanthin compositions, which contain at least 50 wt.%, in particular at least 60 wt.%, more particularly at least 70 wt.%, especially at least 80 wt.% or at least 90 wt.%, relative to the total weight of astaxanthin and astaxanthin derivatives in the composition, a monoester of the astaxanthin having an aliphatic, unbranched C